| Standard Report | Premium Report | |
|---|---|---|
| Current State of the Industry |  |
|
| Market Size (industry trends) | |
|
| Market Forecast (5-year projection) | |
|
| Products/Services Breakdown | |
|
| Revenue per State | |
|
| Financial Metrics | |
|
| Salary & Compensation Statistics | |
|
| Public Company Information | |
|
| Key Private Companies | |
|
| Government Vendors | |
|
| Instant Download - Available immediately upon purchase | |
|
Download both PDF and Excel
|
|
|
| Download now: |
2025 U.S. Industry Statistics & Market Forecast - Pharmaceutical Preparation Manufacturing
Market Size & Industry Statistics
The total U.S. industry market size for Pharmaceutical Preparation Manufacturing:
Industry statistics cover all companies in the United States, both public and private, ranging in size from small businesses to market leaders.
In addition to revenue, the industry market analysis shows information on employees, companies, and average firm size.
Investors, banks, and business executives use growth rates and industry trends to understand the market outlook and opportunity.
| Statistics | 2020 2021 2022 2023 2024 | |
|---|---|---|
| Market Size (Total Sales/Revenue) |
Order at top of page | |
| Total Firms | ||
| Total Employees | ||
| Average Revenue Per Firm | ||
| Average Employees Per Firm | ||
| Average Revenue Per Employee | ||
Market Forecast
Market forecasts show the long term industry outlook and future growth trends. The following extended five-year forecast projects both short-term and long-term trends.
| Forecast / Industry Outlook | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| Market Forecast ($ millions) | |||||
| Projected Industry Growth Rate (%) | |||||
Industry Insights
Major trends affect the Pharmaceutical Preparation Manufacturing industry include:- Increased regulation and compliance standards
- Growth in personalized medicine and biologics
- Rise of biosimilars and generic competition
- Advancements in drug delivery technologies
- Integration of artificial intelligence and machine learning
- Higher demand for orphan drugs
- Shift towards patient-centric healthcare models
- Expansion into emerging markets
- Impact of global health crises like pandemics
- Sustainability and ethical sourcing pressures
- Blockchain for tracking and security
- Telemedicine and digital health integration
- Price control and cost pressures from healthcare payers
- Collaborations and partnerships in R&D activities
- Increased investment in mental health drugs
U.S. Geographic Distribution: Revenue Statistics by State
Market Size by State ($ millions) indicates how the industry's competition is distributed throughout the country. State-level information can identify areas with higher and lower industry market share than average.
Income Statement (Average Financial Metrics)
Financial metrics provide a snapshot view of a benchmark "average" company. Key business metrics show revenue and operating costs. The data collected covers both public and private companies.| Industry Average | Percent of Sales (Industry Benchmark) |
|
|---|---|---|
| Total Revenue | Order at top of page |
|
| Operating Revenue | ||
| Cost of Goods Sold | ||
| Gross Profit | ||
Operating Expenses | ||
| Pension, profit sharing plans, stock, annuity | ||
| Repairs | ||
| Rent paid on business property | ||
| Charitable Contributions | ||
| Depletion | ||
| Domestic production activities deduction | ||
| Advertising | ||
| Compensation of officers | ||
| Salaries and wages | ||
| Employee benefit programs | ||
| Taxes and Licenses | ||
| Bad Debts | ||
| Depreciation | ||
| Amortization | ||
| Other Operating Expenses | ||
| Total Operating Expenses | ||
| Operating Income | ||
| Non-Operating Income | ||
| EBIT (Earnings Before Interest and Taxes) | ||
| Interest Expense | ||
| Earnings Before Taxes | ||
| Income Tax | ||
| Net Profit Net Income | ||
Financial Ratio Analysis
Financial ratio information can be used to benchmark how a Pharmaceutical Preparation Manufacturing company compares to its peers. Accounting statistics are calculated from the industry-average for income statements and balance sheets.| Profitability & Valuation Ratios | Industry Average |
|---|---|
| Company valuation can be measured based on the firm's own performance, as well as in comparison against its industry competitors. These metrics show how the average company in the Pharmaceutical Preparation Manufacturing industry is performing. | |
| Profit Margin Gross Profit Margin, Operating Profit Margin, and Net Profit Margin. Show company earnings relative to revenues. |
|
| Return on Equity (ROE) Return on Equity (ROE) is net income as a percentage of shareholders' equity. Shareholders' Equity is defined as the company's total assets minus total liabilities. ROE shows how much profits a company generates with the money shareholders invested (or with retained earnings). |
|
| Return on Assets (ROA) Return on Assets (ROA) is net income relative to total assets. The market research on Pharmaceutical Preparation Manufacturing measures how efficiently the company leverages its assets to generate profit. ROA is calculated as Net Income divided by Total Assets. |
|
| Liquidity Ratios | Industry Average |
|---|---|
| Bankers and suppliers use liquidity to determine creditworthiness and identify potential threats to a company's financial viability. | |
| Current Ratio Measures a firm's ability to pay its debts over the next 12 months. |
|
| Quick Ratio (Acid Test) Calculates liquid assets relative to liabilities, excluding inventories. |
|
| Efficiency Ratios - Key Performance Indicators | Industry Average |
|---|---|
| Measure how quickly products and services sell, and effectively collections policies are implemented. | |
| Receivables Turnover Ratio If this number is low in your business when compared to the industry average in the research report, it may mean your payment terms are too lenient or that you are not doing a good enough job on collections. |
|
| Average Collection Period Based on the Receivables Turnover, this estimates the collection period in days. Calculated as 365 divided by the Receivables Turnover |
|
| Inventory Turnover A low turnover rate may point to overstocking, obsolescence, or deficiencies in the product line or marketing effort. |
|
| Fixed-Asset Turnover Generally, higher is better, since it indicates the business has less money tied up in fixed assets for each dollar of sales revenue. |
|
Compensation & Salary Surveys for Employees
Compensation statistics provides an accurate assessment of industry-specific jobs and national salary averages. This information can be used to identify which positions are most common, and high, low, and average annual wages.| Title | Percent of Workforce | Bottom Quartile | Average (Median) Salary | Upper Quartile |
|---|---|---|---|---|
| Management Occupations | 12% | Order at top of page |
||
| Chief Executives | 0% | |||
| General and Operations Managers | 2% | |||
| Operations Specialties Managers | 5% | |||
| Business and Financial Operations Occupations | 8% | |||
| Business Operations Specialists | 7% | |||
| Architecture and Engineering Occupations | 5% | |||
| Life, Physical, and Social Science Occupations | 14% | |||
| Life Scientists | 5% | |||
| Office and Administrative Support Occupations | 8% | |||
| Production Occupations | 34% | |||
| Other Production Occupations | 29% | |||
| Chemical Processing Machine Setters, Operators, and Tenders | 9% | |||
| Chemical Equipment Operators and Tenders | 8% | |||
| Packaging and Filling Machine Operators and Tenders | 10% | |||
| Packaging and Filling Machine Operators and Tenders | 10% | |||
| Transportation and Material Moving Occupations | 5% | |||
Pharmaceutical Preparation Manufacturing Competitor Landscape & Key Companies [PREMIUM]
The most influential companies in the Pharmaceutical Preparation Manufacturing industry and adjacent industries either have large market share or are developing new business models and methods that could disrupt the status quo. We look at leading and emerging companies in the Pharmaceutical Preparation Manufacturing industry and adjacent sectors:| Market Leaders: Direct Competitors Companies with the largest market share, focused in this industry |
Market leaders: Diversified Competitors Largest companies that have diversified operations in this and other industries |
| Innovators: Direct Competitors Innovative, Emerging, and Disruptive Companies that may influence the future direction of the industry. |
Innovators: Diversified Competitors Innovators and Disruptors in adjacent industries that may also affect the Pharmaceutical Preparation Manufacturing industry. |
Source:
Latest Industry News
- Trump's threatened 200% pharma tariff 'would damage everybody' – Micheál Martin - The introduction of a 200% tariff rate on pharmaceutical imports to the United States would damage pharma companies and patients, Taoiseach Micheál Martin has said. Earlier this week, US president Donald Trump signalled tariffs against the pharmaceutical industry, (07/10/2025)
- Retail investors drive demand for Asston Pharmaceuticals IPO; GMP at 24% - Asston Pharmaceutical IPO was oversubscribed by 6.26 times, receiving bids for 10 million shares against 1.6 million shares on offer. (07/10/2025)
- GenScript Biotech Earns EcoVadis Silver Medal, Ranking in Top 15% Globally for Sustainability - GenScript Biotech Corporation (HK.1548), a leading global provider of life science research and manufacturing services, today announced that it has been awarded a Silver Medal by EcoVadis, a globally recognized business sustainability assessment platform. (07/09/2025)
- Factory output posts faster growth in May - The country’s manufacturing output grew at a faster rate in May due mainly to increases in the production of food and transport equipment, according to the Philippine Statistics Authority. (07/08/2025)
- Sai Parenterals raises Rs 50 Cr in equity to expand global footprint - The company said the capital will be used to fuel its global expansion strategy, including acquisitions in regulated markets, enhancement of its manufacturing footprint, and diversification of its product portfolio. (07/08/2025)
- The U.S. Imports More of This Than Anything Else - Pharmaceutical preparations are the U.S.'s top import, reflecting the country's heavy reliance on foreign-made medications and the ongoing need for prescription drugs. (07/07/2025)
- Factory gate prices drop at faster pace in May - Producer prices posted a bigger drop in May from the previous month, driven mainly by the decline in prices of computer, electronic and optical products, according to the Philippine Statistics Authority. (07/05/2025)
- California Manufacturing Jobs Dip But Still Key to State as Investment Continues - California’s life sciences manufacturing jobs dipped 3.7% in 2024, according to a new Biocom California report. Still, several companies made—and continuing making—significant manufacturing investments in the state as key trends shape the discipline. (07/02/2025)
- Vetter Marks the Start of New Clinical Site Construction with Groundbreaking Ceremony - © Vetter Pharma International GmbH: Vetter marks the start of new clinical site construction with groundbreaking ceremony. Participants from left to right: Tom Kikta, Wolfgang Kerkhoff, Gunther Strothe, Dr. Susanne Lemaine, Senator h.c. Udo J. Vetter, Andrew Goczkowski, Thomas Otto, Thomas Ruebekeil, Henryk Badack, RT Evans. (06/30/2025)
- Vetter breaks ground on $285m US clinical manufacturing site - Vetter Pharma, has begun the construction of a new clinical manufacturing facility in Des Plaines, Illinois, US. (06/30/2025)
Related Reports
Can't find what you're looking for? We have over a thousand
market research reports.
Ask us and an analyst will help you find what you need.